Vizionfocus Inc. (4771) - Net Assets

Latest as of March 2026: NT$4.71 Billion TWD ≈ $148.50 Million USD

Based on the latest financial reports, Vizionfocus Inc. (4771) has net assets worth NT$4.71 Billion TWD (≈ $148.50 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$7.44 Billion ≈ $234.38 Million USD) and total liabilities (NT$2.73 Billion ≈ $85.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Vizionfocus Inc. 's equity to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$4.71 Billion
% of Total Assets 63.36%
Annual Growth Rate 27.87%
5-Year Change 144.37%
10-Year Change N/A
Growth Volatility 31.64

Vizionfocus Inc. - Net Assets Trend (2020–2025)

This chart illustrates how Vizionfocus Inc. 's net assets have evolved over time, based on quarterly financial data. See Vizionfocus Inc. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Vizionfocus Inc. (2020–2025)

The table below shows the annual net assets of Vizionfocus Inc. from 2020 to 2025. For live valuation and market cap data, see market cap of Vizionfocus Inc. .

Year Net Assets Change
2025-12-31 NT$4.42 Billion
≈ $139.26 Million
+14.82%
2024-12-31 NT$3.85 Billion
≈ $121.28 Million
+89.11%
2023-12-31 NT$2.04 Billion
≈ $64.13 Million
+0.67%
2022-12-31 NT$2.02 Billion
≈ $63.71 Million
+11.79%
2021-12-31 NT$1.81 Billion
≈ $56.99 Million
+39.87%
2020-12-31 NT$1.29 Billion
≈ $40.75 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Vizionfocus Inc. 's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3876.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$1.37 Billion 34.35%
Common Stock NT$585.28 Million 14.69%
Other Comprehensive Income NT$184.88 Million 4.64%
Other Components NT$1.85 Billion 46.32%
Total Equity NT$3.98 Billion 100.00%

Vizionfocus Inc. Competitors by Market Cap

The table below lists competitors of Vizionfocus Inc. ranked by their market capitalization.

Company Market Cap
Erajaya Swasembada Tbk
JK:ERAA
$349.59 Million
Hai An Transport and Stevedoring JSC
VN:HAH
$349.66 Million
Cosmo Chem
KO:005420
$349.69 Million
SFC Energy AG
XETRA:F3C
$349.70 Million
Caledonia Mining Corporation Plc
F:9CD1
$349.57 Million
Qingdao Victall Railway Co Ltd
SHG:605001
$349.55 Million
Seah Holdings
KO:058650
$349.54 Million
Rojana Industrial Park Public Company Limited
BK:ROJNA
$349.52 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vizionfocus Inc. 's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,532,735,000 to 3,984,501,000, a change of 451,766,000 (12.8%).
  • Net income of 807,938,000 contributed positively to equity growth.
  • Dividend payments of 322,638,000 reduced retained earnings.
  • New share issuances of 22,125,000 increased equity.
  • Other comprehensive income increased equity by 184,879,000.
  • Other factors decreased equity by 240,538,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$807.94 Million +20.28%
Dividends Paid NT$322.64 Million -8.1%
Share Issuances NT$22.12 Million +0.56%
Other Comprehensive Income NT$184.88 Million +4.64%
Other Changes NT$-240.54 Million -6.04%
Total Change NT$- 12.79%

Book Value vs Market Value Analysis

This analysis compares Vizionfocus Inc. 's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.02x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 9.33x to 3.02x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 NT$20.26 NT$189.00 x
2021-12-31 NT$27.41 NT$189.00 x
2022-12-31 NT$30.65 NT$189.00 x
2023-12-31 NT$33.34 NT$189.00 x
2024-12-31 NT$60.04 NT$189.00 x
2025-12-31 NT$62.68 NT$189.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vizionfocus Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 20.28%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 23.17%
  • • Asset Turnover: 0.49x
  • • Equity Multiplier: 1.77x
  • Recent ROE (20.28%) is above the historical average (20.12%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 14.46% 17.12% 0.39x 2.16x NT$45.18 Million
2021 16.44% 16.49% 0.49x 2.03x NT$91.72 Million
2022 19.10% 17.06% 0.57x 1.96x NT$149.16 Million
2023 31.46% 21.86% 0.58x 2.50x NT$383.56 Million
2024 18.95% 22.30% 0.51x 1.68x NT$316.32 Million
2025 20.28% 23.17% 0.49x 1.77x NT$409.49 Million

Industry Comparison

This section compares Vizionfocus Inc. 's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $1,419,230,667
  • Average return on equity (ROE) among peers: 12.76%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Vizionfocus Inc. (4771) NT$4.71 Billion 14.46% 0.58x $349.58 Million
St.Shine Optical Co Ltd (1565) $966.82 Million 24.11% 0.40x $147.72 Million
Maxigen Biotech Inc (1783) $860.23 Million 7.36% 0.11x $110.19 Million
SciVision Biotech Inc (1786) $425.98 Million 14.66% 0.13x $132.02 Million
Bioteque (4107) $3.19 Billion 14.19% 0.45x $254.35 Million
Chi Sheng Chemical (4111) $1.22 Billion 12.60% 0.47x $56.46 Million
BenQ Medical Technology (4116) $1.09 Billion 6.10% 0.54x $53.07 Million
Pacific Hospital Supply Co Ltd (4126) $2.02 Billion 17.37% 0.32x $184.13 Million
Bionime Corp (4737) $2.07 Billion 3.01% 1.17x $133.68 Million
Formosa Optical Technology Co Ltd (5312) $922.41 Million 15.48% 0.58x $181.65 Million

About Vizionfocus Inc.

TW:4771 Taiwan Medical Instruments & Supplies
Market Cap
$349.58 Million
NT$11.10 Billion TWD
Market Cap Rank
#14236 Global
#605 in Taiwan
Share Price
NT$189.00
Change (1 day)
-0.26%
52-Week Range
NT$170.00 - NT$207.00
All Time High
NT$357.69
About

Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, OEM, development, and sale of contact lenses, as… Read more